{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:11:34Z","timestamp":1791569494289,"version":"4.3.4"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>When discovered in the early 2000s, interleukin-33 (IL-33) was characterized as a potent driver of type 2 immunity and implicated in parasite clearance, as well as asthma, allergy, and lung fibrosis. Yet research in other models has since revealed that IL-33 is a highly pleiotropic molecule with diverse functions. These activities are supported by elusive release mechanisms and diverse expression of the IL-33 receptor, STimulation 2 (ST2), on both immune and stromal cells. Interestingly, IL-33 also supports type 1 immune responses during viral and tumor immunity and after allogeneic hematopoietic stem cell transplantation. Yet the IL-33\u2013ST2 axis is also critical to the establishment of systemic homeostasis and tissue repair and regeneration. Despite these recent findings, the mechanisms by which IL-33 governs the balance between immunity and homeostasis or can support both effective repair and pathogenic fibrosis are poorly understood. As such, ongoing research is trying to understand the potential reparative and regulatory versus pro-inflammatory and pro-fibrotic roles for IL-33 in transplantation. This review provides an overview of the emerging regenerative role of IL-33 in organ homeostasis and tissue repair as it relates to transplantation immunology. It also outlines the known impacts of IL-33 in commonly transplanted solid organs and covers the envisioned roles for IL-33 in ischemia-reperfusion injury, rejection, and tolerance. Finally, we give a comprehensive summary of its effects on different cell populations involved in these processes, including ST2<jats:sup>+<\/jats:sup> regulatory T cells, innate lymphoid cell type 2, as well as significant myeloid cell populations.<\/jats:p>","DOI":"10.1097\/tp.0000000000004447","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:36:58Z","timestamp":1674866218000},"page":"1069-1078","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["The Reparative Roles of IL-33"],"prefix":"10.1097","volume":"107","author":[{"given":"Johnny","family":"Bou Saba","sequence":"first","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0304th R.","family":"Turnquist","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family.","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease.","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ni.3370","article-title":"Interleukin 33 is a guardian of barriers and a local alarmin.","volume":"17","author":"Martin","year":"2016","journal-title":"Nat Immunol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","article-title":"Emerging functions of IL-33 in homeostasis and immunity.","volume":"40","author":"Dwyer","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.","volume":"111","author":"Lefrancais","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/cells11010107","article-title":"IL-33, an alarmin of the IL-1 family involved in allergic and non allergic inflammation: focus on the mechanisms of regulation of its activity.","volume":"11","author":"Cayrol","year":"2021","journal-title":"Cells"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2014-10-606830","article-title":"The IL-33\/ST2 axis augments effector T-cell responses during acute GVHD.","volume":"125","author":"Reichenbach","year":"2015","journal-title":"Blood"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors.","volume":"132","author":"Savinko","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.3390\/ijms22147443","article-title":"Regulatory T cells exhibit interleukin-33-dependent migratory behavior during skin barrier disruption.","volume":"22","author":"Toyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.2353\/ajpath.2010.100378","article-title":"Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.","volume":"177","author":"Sponheim","year":"2010","journal-title":"Am J Pathol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"611910","DOI":"10.3389\/fimmu.2021.611910","article-title":"Untangling local pro-inflammatory, reparative, and regulatory damage-associated molecular-patterns (DAMPs) pathways to improve transplant outcomes.","volume":"12","author":"Dwyer","year":"2021","journal-title":"Front Immunol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"eabc6259","DOI":"10.1126\/sciimmunol.abc6259","article-title":"Cellular context of IL-33 expression dictates impact on anti-helminth immunity.","volume":"5","author":"Hung","year":"2020","journal-title":"Sci Immunol"},{"key":"R14-20250604","first-page":"e136166","article-title":"Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease.","volume":"6","author":"Katz-Kiriakos","year":"2021","journal-title":"JCI Insight"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2020.07.127","article-title":"The Ca(2+)-dependent pathway contributes to changes in the subcellular localization and extracellular release of interleukin-33.","volume":"530","author":"Momota","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.immuni.2017.08.004","article-title":"IL-1 family cytokines use distinct molecular mechanisms to signal through their shared co-receptor.","volume":"47","author":"Gunther","year":"2017","journal-title":"Immunity"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.smim.2013.10.006","article-title":"Special aspects of interleukin-33 and the IL-33 receptor complex.","volume":"25","author":"Martin","year":"2013","journal-title":"Semin Immunol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation.","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair.","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"R20-20250604","first-page":"e123919","article-title":"IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury.","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine.","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity.","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41467-020-18466-w","article-title":"IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration.","volume":"11","author":"Dagher","year":"2020","journal-title":"Nat Commun"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1172\/JCI133008","article-title":"Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.","volume":"130","author":"Li","year":"2020","journal-title":"J Clin Invest"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood-2015-12-684142","article-title":"Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.","volume":"128","author":"Matta","year":"2016","journal-title":"Blood"},{"key":"R26-20250604","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150927","article-title":"IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.","volume":"132","author":"Dwyer","year":"2022","journal-title":"J Clin Invest"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.1701757","article-title":"IL-33 augments virus-specific memory T cell inflation and potentiates the efficacy of an attenuated cytomegalovirus-based vaccine.","volume":"202","author":"McLaren","year":"2019","journal-title":"J Immunol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3389\/fimmu.2018.02601","article-title":"The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity.","volume":"9","author":"Afferni","year":"2018","journal-title":"Front Immunol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.012","article-title":"Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation.","volume":"55","author":"Bessa","year":"2014","journal-title":"J Autoimmun"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Commun"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J Biol Chem"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/eji.201142274","article-title":"Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation.","volume":"42","author":"Lipsky","year":"2012","journal-title":"Eur J Immunol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fphys.2020.00200","article-title":"Homeostasis: the underappreciated and far too often ignored central organizing principle of physiology.","volume":"11","author":"Billman","year":"2020","journal-title":"Front Physiol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/mi.2013.124","article-title":"IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.","volume":"7","author":"Guabiraba","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.celrep.2016.04.049","article-title":"Programming of intestinal epithelial differentiation by IL-33 derived from pericryptal fibroblasts in response to systemic infection.","volume":"15","author":"Mahapatro","year":"2016","journal-title":"Cell Rep"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2020.10.014","article-title":"Interleukin-33 promotes serotonin release from enterochromaffin cells for intestinal homeostasis.","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.immuni.2016.10.031","article-title":"Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung.","volume":"45","author":"de Kleer","year":"2016","journal-title":"Immunity"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus.","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2017.01.071","article-title":"First-breath-induced type 2 pathways shape the lung immune environment.","volume":"18","author":"Saluzzo","year":"2017","journal-title":"Cell Rep"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/imr.12850","article-title":"Visceral adipose tissue Tregs and the cells that nurture them.","volume":"295","author":"Li","year":"2020","journal-title":"Immunol Rev"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","article-title":"Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF.","volume":"52","author":"Delacher","year":"2020","journal-title":"Immunity"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat Immunol"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41385-020-00351-w","article-title":"Metabolic regulation by PPAR","volume":"14","author":"Fali","year":"2021","journal-title":"Mucosal Immunol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain isceral adipose tissue eosinophils and alternatively activated macrophages.","volume":"210","author":"Molofsky","year":"2013","journal-title":"J Exp Med"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00011-019-01214-2","article-title":"IL-33 in obesity: where do we go from here?","volume":"68","author":"de Oliveira","year":"2019","journal-title":"Inflamm Res"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis.","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"669629","DOI":"10.3389\/fimmu.2021.669629","article-title":"ILC2s improve glucose metabolism through the control of saturated fatty acid absorption within visceral fat.","volume":"12","author":"Okamura","year":"2021","journal-title":"Front Immunol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.cmet.2021.08.004","article-title":"IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2.","volume":"33","author":"Goldberg","year":"2021","journal-title":"Cell Metab"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"eaay6191","DOI":"10.1126\/sciadv.aay6191","article-title":"The obesity-induced adipokine sST2 exacerbates adipose Treg and ILC2 depletion and promotes insulin resistance.","volume":"6","author":"Zhao","year":"2020","journal-title":"Sci Adv"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.4049\/jimmunol.1300490","article-title":"Macrophage-derived IL-33 is a critical factor for placental growth.","volume":"191","author":"Fock","year":"2013","journal-title":"J Immunol"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/14767058.2012.735724","article-title":"Interleukin-33 in the human placenta.","volume":"26","author":"Topping","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"9787239","DOI":"10.1155\/2018\/9787239","article-title":"Decreased IL-33 production contributes to trophoblast cell dysfunction in pregnancies with preeclampsia.","volume":"2018","author":"Chen","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jri.2015.01.004","article-title":"Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-","volume":"109","author":"Hu","year":"2015","journal-title":"J Reprod Immunol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"11918","DOI":"10.1073\/pnas.1001749107","article-title":"Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression.","volume":"107","author":"Vacca","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis.","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Immunol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2012.05.031","article-title":"Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict.","volume":"150","author":"Samstein","year":"2012","journal-title":"Cell"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4049\/jimmunol.1602085","article-title":"IL-33-responsive group 2 innate lymphoid cells are regulated by female sex hormones in the uterus.","volume":"200","author":"Bartemes","year":"2018","journal-title":"J Immunol"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"e21272","DOI":"10.1096\/fj.202001782RR","article-title":"Protective role of IL33 signaling in negative pregnancy outcomes associated with lipopolysaccharide exposure.","volume":"35","author":"Kozai","year":"2021","journal-title":"FASEB J"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2020.00446","article-title":"Expression of IL-33 receptor Is Significantly Up-Regulated In B cells during pregnancy and in the acute phase of preterm birth in mice.","volume":"11","author":"Valeff","year":"2020","journal-title":"Front Immunol"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4244","article-title":"Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor.","volume":"23","author":"Huang","year":"2017","journal-title":"Nat Med"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/TP.0000000000002815","article-title":"Diabetogenic effects of immunosuppression: An integrative analysis.","volume":"104","author":"Bhat","year":"2020","journal-title":"Transplantation"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/TP.0b013e3181f1543c","article-title":"Association of metabolic syndrome with development of new-onset diabetes after transplantation.","volume":"90","author":"Bayer","year":"2010","journal-title":"Transplantation"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1172\/JCI124617","article-title":"LongmanThe balance of power: innate lymphoid cells in tissue inflammation and repair.","volume":"129","author":"Jim","year":"2019","journal-title":"J Clin Invest"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/JID.2015.406","article-title":"IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing.","volume":"136","author":"Rak","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.4049\/jimmunol.0903356","article-title":"Differential roles of macrophages in diverse phases of skin repair.","volume":"184","author":"Lucas","year":"2010","journal-title":"J Immunol"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molimm.2013.05.225","article-title":"IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages.","volume":"56","author":"Yin","year":"2013","journal-title":"Mol Immunol"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/exd.12833","article-title":"ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis.","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Dermatol"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"12080","DOI":"10.1038\/ncomms12080","article-title":"IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin.","volume":"7","author":"Dalessandri","year":"2016","journal-title":"Nat Commun"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/wrr.12687","article-title":"Interleukin-33 encourages scar formation in murine fetal skin wounds.","volume":"27","author":"Wulff","year":"2019","journal-title":"Wound Repair Regen"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis.","volume":"184","author":"Rankin","year":"2010","journal-title":"J Immunol"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells.","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system.","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","article-title":"Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration.","volume":"153","author":"Heredia","year":"2013","journal-title":"Cell"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ibd.22900","article-title":"IL-33 attenuates development and perpetuation of chronic intestinal inflammation.","volume":"18","author":"Grobeta","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2119\/molmed.2011.00428","article-title":"Interleukin-33 ameliorates experimental colitis through promoting Th2\/Foxp3(+) regulatory T-cell responses in mice.","volume":"18","author":"Duan","year":"2012","journal-title":"Mol Med"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.intimp.2015.08.032","article-title":"IL-33 alleviates DSS-induced chronic colitis in C57BL\/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response.","volume":"29","author":"Zhu","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions.","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"913041","DOI":"10.1155\/2015\/913041","article-title":"IL-33 aggravates DSS-induced acute colitis in mouse colon lamina propria by enhancing Th2 cell responses.","volume":"2015","author":"Zhu","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcmgh.2014.12.003","article-title":"IL33 is a stomach alarmin that initiates a skewed Th2 response to injury and infection.","volume":"1","author":"Buzzelli","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/ijms21051801","article-title":"Proregenerative activity of IL-33 in gastric tissue cells undergoing helicobacter pylori-induced apoptosis.","volume":"21","author":"Gonciarz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","article-title":"IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.","volume":"187","author":"Turnquist","year":"2011","journal-title":"J Immunol"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/TP.0b013e3181d720af","article-title":"IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation.","volume":"89","author":"Yin","year":"2010","journal-title":"Transplantation"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1432-2277.2011.01306.x","article-title":"Interleukin-33 prolongs allograft survival during chronic cardiac rejection.","volume":"24","author":"Brunner","year":"2011","journal-title":"Transpl Int"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cvr\/cvs015","article-title":"Reduction in IL-33 expression exaggerates ischaemia\/reperfusion-induced myocardial injury in mice with diabetes mellitus.","volume":"94","author":"Rui","year":"2012","journal-title":"Cardiovasc Res"},{"key":"R86-20250604","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143064","article-title":"The protective role of interleukin-33 in myocardial ischemia and reperfusion is associated with decreased HMGB1 expression and up-regulation of the P38 MAPK signaling pathway.","volume":"10","author":"Ruisong","year":"2015","journal-title":"PLoS One"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ajt.13542","article-title":"Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection.","volume":"16","author":"Mathews","year":"2016","journal-title":"Am J Transplant"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.athoracsur.2011.07.048","article-title":"Soluble ST2 is a marker for acute cardiac allograft rejection.","volume":"92","author":"Pascual-Figal","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"e13349","DOI":"10.1111\/ctr.13349","article-title":"Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients.","volume":"32","author":"Grupper","year":"2018","journal-title":"Clin Transplant"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease.","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"e88742","DOI":"10.1371\/journal.pone.0088742","article-title":"The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33.","volume":"9","author":"Thierry","year":"2014","journal-title":"PLoS One"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"611","DOI":"10.12659\/AOT.899263","article-title":"The potential role of IL-33 in renal transplant recipients with chronic allograft dysfunction.","volume":"21","author":"Zhang","year":"2016","journal-title":"Ann Transplant"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2017070774","article-title":"Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury.","volume":"29","author":"Cao","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur J Immunol"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.4049\/jimmunol.178.9.5899","article-title":"NKT cell activation mediates neutrophil IFN-\u03b3 production and renal ischemia-reperfusion injury.","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/TP.0000000000003782","article-title":"Innate (and innate-like) lymphoid cells: emerging immune subsets with multiple roles along transplant life.","volume":"105","author":"Charmetant","year":"2021","journal-title":"Transplantation"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1681\/ASN.2017060650","article-title":"Endogenous IL-33 contributes to kidney ischemia-reperfusion injury as an alarmin.","volume":"29","author":"Ferhat","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/TP.0000000000004038","article-title":"DAMPs released from injured renal tubular epithelial cells activate innate immune signals in healthy renal tubular epithelial cells.","volume":"106","author":"DeWolf","year":"2022","journal-title":"Transplantation"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"112705","DOI":"10.1016\/j.yexcr.2021.112705","article-title":"Role of the IL-33\/ST2 pathway in renal allograft rejection.","volume":"405","author":"Yu","year":"2021","journal-title":"Exp Cell Res"},{"key":"R100-20250604","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2017.11.010","article-title":"Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells.","volume":"644","author":"Xu","year":"2018","journal-title":"Gene"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis.","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/TP.0000000000003678","article-title":"Kidney allograft fibrosis: diagnostic and therapeutic strategies.","volume":"105","author":"Saritas","year":"2021","journal-title":"Transplantation"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"744927","DOI":"10.3389\/fimmu.2021.744927","article-title":"Endogenous interleukin-33 acts as an alarmin in liver ischemia-reperfusion and is associated with injury after human liver transplantation.","volume":"12","author":"Barbier","year":"2021","journal-title":"Front Immunol"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/TP.0000000000001411","article-title":"Innate immune regulations and liver ischemia-reperfusion injury.","volume":"100","author":"Lu","year":"2016","journal-title":"Transplantation"},{"key":"R105-20250604","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2017.09.010","article-title":"IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation.","volume":"68","author":"Yazdani","year":"2017","journal-title":"J Hepatol"},{"key":"R106-20250604","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/hep.25768","article-title":"Interleukin-33 is hepatoprotective during liver ischemia\/reperfusion in mice.","volume":"56","author":"Sakai","year":"2012","journal-title":"Hepatology"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3389\/fimmu.2018.02308","article-title":"The impact of invariant NKT cells in sterile inflammation: The possible contribution of the alarmin\/cytokine IL-33.","volume":"9","author":"Ferhat","year":"2018","journal-title":"Front Immunol"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"eabb6576","DOI":"10.1126\/scitranslmed.abb6576","article-title":"Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production.","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/ajt.17084","article-title":"Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.","volume":"22","author":"Guo","year":"2022","journal-title":"Am J Transplant"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/ajt.16266","article-title":"IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation.","volume":"21","author":"Kawai","year":"2021","journal-title":"Am J Transplant"},{"key":"R111-20250604","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.4049\/jimmunol.1502537","article-title":"T-bet regulates natural regulatory T cell afferent lymphatic migration and suppressive function.","volume":"196","author":"Xiong","year":"2016","journal-title":"J Immunol"},{"key":"R112-20250604","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1097\/TP.0000000000001757","article-title":"Harnessing advances in T regulatory cell biology for cellular therapy in transplantation.","volume":"101","author":"Lam","year":"2017","journal-title":"Transplantation"},{"key":"R113-20250604","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.1801330","article-title":"Innate control of tissue-reparative human regulatory T cells.","volume":"202","author":"Lam","year":"2019","journal-title":"J Immunol"},{"key":"R114-20250604","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imm.12483","article-title":"Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3(+) regulatory T cells in skin-transplanted mice.","volume":"146","author":"Gajardo","year":"2015","journal-title":"Immunology"},{"key":"R115-20250604","doi-asserted-by":"crossref","first-page":"108850","DOI":"10.1016\/j.intimp.2022.108850","article-title":"Interleukin-33 protects mice against hindlimb ischemic injury by enhancing endothelial angiogenesis.","volume":"109","author":"Dong","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R116-20250604","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41563-020-00844-w","article-title":"Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing.","volume":"20","author":"Griffin","year":"2021","journal-title":"Nat Mater"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:12:49Z","timestamp":1749060769000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004447","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,22]]}}}